IFN-BETA MODULATES IMMUNE FUNCTION - IMPLICATIONS FOR MULTIPLE-SCLEROSIS (MS)

被引：0
|
作者：
NORONHA, A [1 ]
TOSCAS, A [1 ]
JENSEN, MA [1 ]
机构：
[1] UNIV CHICAGO,DEPT NEUROL,CHICAGO,IL 60637
来源：
JOURNAL OF IMMUNOLOGY | 1993年 / 150卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 50 条
  • [1] INTERFERON-BETA (IFN-BETA) INDUCTION IN MULTIPLE-SCLEROSIS (MS) INCREASES INTERFERON-GAMMA (IFN-GAMMA)-SECRETING CELLS
    ARNASON, BGW
    JENSEN, M
    LLEDO, A
    DAYAL, A
    NEUROLOGY, 1995, 45 (04) : A437 - A437
  • [2] Clinical impact of antibodies to IFN-beta in multiple sclerosis
    Pachner, Andrew R.
    INFLAMMATION RESEARCH, 2007, 56 : S353 - S353
  • [3] IMMUNOREGULATORY EFFECTS OF IFN-BETA AND INTERACTING CYTOKINES ON HUMAN MICRO-VESSEL ENDOTHELIAL-CELLS - IMPLICATIONS FOR MULTIPLE-SCLEROSIS
    MILLER, A
    LANIR, N
    REVEL, M
    HONIGMAN, S
    KINARTY, A
    LAHAT, N
    NEUROLOGY, 1995, 45 (04) : A196 - A196
  • [4] IFN-beta impairs plasmacytoid dendritic cell maturation: A novel target for IFN-beta therapy in multiple sclerosis
    Lande, Roberto
    Gafa, Valerie
    Serafini, Barbara
    Giacomini, Elena
    Salvetti, Marco
    Remoli, Maria E.
    Severa, Martina
    Parmentier, Marc
    Aloisi, Francesca
    Coccia, Eliana M.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 705 - 705
  • [5] IFN-GAMMA, IFN-BETA, AND PGE(1) AFFECT MONOKINE SECRETION - RELEVANCE TO MONOCYTE ACTIVATION IN MULTIPLE-SCLEROSIS
    PORRINI, AM
    REDER, AT
    CELLULAR IMMUNOLOGY, 1994, 157 (02) : 428 - 438
  • [6] IFN-beta biological activity for the management of multiple sclerosis patients
    Hillert, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 636 - 636
  • [7] IFN-BETA AUGMENTS IN-VIVO SUPPRESSOR FUNCTION IN MS
    NORONHA, A
    TOSCAS, A
    ARNASON, BGW
    JENSEN, M
    NEUROLOGY, 1994, 44 (04) : A212 - A212
  • [8] EFFECT OF IMURAN THERAPY ON INVITRO IMMUNE FUNCTION IN MULTIPLE-SCLEROSIS (MS)
    ANTEL, JP
    OGER, JJF
    ARNASON, BGW
    NEUROLOGY, 1981, 31 (04) : 137 - 137
  • [9] Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-beta
    Bustamante, Marta F.
    Morcillo-Suarez, Carlos
    Malhotra, Sunny
    Rio, Jordi
    Leyva, Laura
    Fernandez, Oscar
    Zettl, Uwe K.
    Killestein, Joep
    Brassat, David
    Garcia-Merino, Juan Antonio
    Sanchez, Antonio J.
    Urcelay, Elena
    Alvarez-Lafuente, Roberto
    Villar, Lusia M.
    Alvarez-Cermeno, Jose Carlos
    Farre, Xavier
    Lechner-Scott, Jeannette
    Vandenbroeck, Koen
    Rodriguez-Antigedad, Alfredo
    Drulovic, Jelena S.
    Boneschi, Filippo Martinelli
    Chan, Andrew
    Oksenberg, Jorge
    Navarro, Arcadi
    Montalban, Xavier
    Comabella, Manuel
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2015, 2 (05): : e154
  • [10] Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
    Aliaga-Gaspar, Pablo
    Hurtado-Guerrero, Isaac
    Ciano-Petersen, Nicolas Lundahl
    Urbaneja, Patricia
    Brichette-Mieg, Isabel
    Reyes, Virginia
    Rodriguez-Bada, Jose Luis
    Alvarez-Lafuente, Roberto
    Arroyo, Rafael
    Quintana, Ester
    Ramio-Torrenta, Lluis
    Alonso, Ana
    Leyva, Laura
    Fernandez, Oscar
    Oliver-Martos, Begona
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345